Kenvue Inc.

NYSE:KVUE

Sector

🛒 Consumer Staples

Industries

🧴 Personal Care

💄 Cosmetics

Location

United States

Market Cap

USD 41.07 B

Share Price

USD 21.39

Avg Daily Volume

18,219,250

Change (1 day)

0.14%

Change (1 year)

13.54%

Change (YTD)

0.19%

Kenvue Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 30, 2025: USD 0.00

Kenvue Inc. Common Stock Issued is USD 0.00 for the Trailing 12 Months (TTM) ending March 30, 2025, a -100.00% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.

Kenvue Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 4.24 B.
Kenvue Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending April 02, 2023 was USD 0.00.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Common Stock Issued	Common Stock Repurchased	Free Cash Flow	Operating Cash Flow

NYSE: KVUE

Kenvue Inc.

CEO	Mr. Thibaut Mongon
IPO Date	May 4, 2023
Location	United States
Headquarters	199 Grandview Road
Employees	22,000
Sector	🛒 Consumer Staples
Industries Personal Care 💄 Cosmetics

Description

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.